Fate Therapeutics Inc

XNAS: FATE

Download real time

0.91 -0.03 (-3.19%)

Near 52W Low of $0.87

1.2M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

104.3

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 16 analysts

Fate Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -69.4%, and profit growth estimate of -4.8% for FY25, based on top 16 analyst calls.

Forecaster Screeners